{"id":"https://openalex.org/W33924344","doi":"https://doi.org/10.1096/fasebj.22.1_supplement.859.14","title":"Development of a Multiplexed HPV L1 Virus\u2010Like Particle Type\u2010Specific Immunoglobulin Subclass and Isotyping Assay","display_name":"Development of a Multiplexed HPV L1 Virus\u2010Like Particle Type\u2010Specific Immunoglobulin Subclass and Isotyping Assay","publication_year":2008,"publication_date":"2008-03-01","ids":{"openalex":"https://openalex.org/W33924344","doi":"https://doi.org/10.1096/fasebj.22.1_supplement.859.14","mag":"33924344"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.22.1_supplement.859.14","doi":"https://doi.org/10.1096/fasebj.22.1_supplement.859.14","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.22.1_supplement.859.14","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004451673","display_name":"David Opalka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David William Opalka","raw_affiliation_strings":["Viral Vaccine Research Merck and Co., Inc. Wayne PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Viral Vaccine Research Merck and Co., Inc. Wayne PA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066426970","display_name":"Katie Matys","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katie Marie Matys","raw_affiliation_strings":["Viral Vaccine Research Merck and Co., Inc. Wayne PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Viral Vaccine Research Merck and Co., Inc. Wayne PA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063458821","display_name":"Tina Green","orcid":"https://orcid.org/0000-0002-4406-9291","observed_orcids":["https://orcid.org/0000-0002-4406-9291"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tina Green","raw_affiliation_strings":["Non\u2010Clinical Statistics Merck and Co., Inc. West Point PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Non\u2010Clinical Statistics Merck and Co., Inc. West Point PA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065104580","display_name":"Joseph M. Antonello","orcid":"https://orcid.org/0000-0003-0160-7456","observed_orcids":["https://orcid.org/0000-0003-0160-7456"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph Antonello","raw_affiliation_strings":["Non\u2010Clinical Statistics Merck and Co., Inc. West Point PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Non\u2010Clinical Statistics Merck and Co., Inc. West Point PA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026102047","display_name":"David R. Radley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Radley","raw_affiliation_strings":["Merck and Co., Inc. Upper Gwynedd PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck and Co., Inc. Upper Gwynedd PA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110036423","display_name":"Daniel J. Sikkema","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Sikkema","raw_affiliation_strings":["Viral Vaccine Research Merck and Co., Inc. Wayne PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Viral Vaccine Research Merck and Co., Inc. Wayne PA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103540365","display_name":"Eliav Barr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eliav Barr","raw_affiliation_strings":["Merck and Co., Inc. Upper Gwynedd PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck and Co., Inc. Upper Gwynedd PA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081967303","display_name":"Mark Thomas Esser","orcid":"https://orcid.org/0000-0003-1689-3475","observed_orcids":["https://orcid.org/0000-0003-1689-3475"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Thomas Esser","raw_affiliation_strings":["Viral Vaccine Research Merck and Co., Inc. Wayne PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Viral Vaccine Research Merck and Co., Inc. Wayne PA","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.00516203,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"22","issue":"S1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10146","display_name":"Cervical Cancer and HPV Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10146","display_name":"Cervical Cancer and HPV Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10428","display_name":"Reproductive tract infections research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/human-papillomavirus","display_name":"human papillomavirus","score":0.8899999856948853},{"id":"https://openalex.org/keywords/immunoglobulin-subclasses","display_name":"immunoglobulin subclasses","score":0.8349999785423279},{"id":"https://openalex.org/keywords/iga","display_name":"IgA","score":0.5590000152587891},{"id":"https://openalex.org/keywords/humoral-immune-response","display_name":"humoral immune response","score":0.9100000262260437},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.8619999885559082},{"id":"https://openalex.org/keywords/mucosal-immunity","display_name":"mucosal immunity","score":0.8410000205039978}],"concepts":[{"id":"https://openalex.org/C2776194381","wikidata":"https://www.wikidata.org/wiki/Q3965271","display_name":"Subclass","level":3,"score":0.6986652612686157},{"id":"https://openalex.org/C2777991845","wikidata":"https://www.wikidata.org/wiki/Q2396793","display_name":"Isotype","level":4,"score":0.6521488428115845},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6505416035652161},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6163821220397949},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6033082008361816},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.5246154069900513},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.45305484533309937},{"id":"https://openalex.org/C2780898057","wikidata":"https://www.wikidata.org/wiki/Q79448","display_name":"Immunoglobulin G","level":3,"score":0.4453495442867279},{"id":"https://openalex.org/C2780420688","wikidata":"https://www.wikidata.org/wiki/Q759183","display_name":"Immunoassay","level":3,"score":0.4274140000343323},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.40387314558029175},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40004396438598633},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.06022605299949646}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.22.1_supplement.859.14","doi":"https://doi.org/10.1096/fasebj.22.1_supplement.859.14","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.22.1_supplement.859.14","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9789000153541565,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2005304154","https://openalex.org/W2047704680","https://openalex.org/W7329232","https://openalex.org/W2195682012","https://openalex.org/W2342213749","https://openalex.org/W2107040986","https://openalex.org/W2099957667","https://openalex.org/W2154225256","https://openalex.org/W2026322085","https://openalex.org/W1991260070"],"abstract_inverted_index":{"GARDASIL\u2122":[0,120],"has":[1],"been":[2],"proven":[3],"in":[4,150],"clinical":[5],"trials":[6],"as":[7],"a":[8,79,109,151],"highly":[9],"effective":[10],"vaccine":[11],"for":[12,96],"preventing":[13],"HPV":[14,45,70,176,195],"6\u2010,":[15],"11\u2010,":[16],"16\u2010,":[17],"or":[18,161],"18\u2010related":[19],"pre\u2010cancerous":[20],"lesions":[21],"and":[22,34,54,60,76,85,131,134,142],"genital":[23],"warts.":[24],"In":[25],"this":[26],"study,":[27],"we":[28],"compared":[29],"the":[30,106,191],"HPV\u2010type":[31],"specific":[32],"subclass":[33,84],"isotype":[35],"humoral":[36],"immune":[37],"responses":[38],"following":[39],"vaccination":[40,181],"to":[41,65,101,113,137,160],"those":[42],"induced":[43,121,179],"by":[44,180],"infection.":[46,196],"Sera":[47],"collected":[48],"from":[49,194],"vaccinees":[50],"at":[51,147],"month":[52,55],"7":[53],"60":[56,149],"post\u2010vaccination,":[57],"naturally":[58,169],"infected":[59,170],"negative":[61],"subjects":[62,168],"were":[63,93,144,158],"tested":[64],"determine":[66],"serum":[67,91,123,174],"levels":[68,98,124,157,165,178],"of":[69,99,125,154,185],"VLP\u2010specific":[71,126],"IgG,":[72,127],"IgG1,":[73,128],"IgG3,":[74,129],"IgG4":[75,130],"IgA":[77,132,177],"using":[78,108],"Luminex":[80],"based,":[81],"direct":[82],"binding,":[83],"isotyping":[86],"assay":[87],"method.":[88],"The":[89],"same":[90],"samples":[92],"also":[94,145],"evaluated":[95],"their":[97],"antibodies":[100,136],"type\u2010specific,":[102,115],"neutralizing":[103,116],"epitopes":[104],"on":[105],"VLPs":[107],"competitive":[110],"immunoassay":[111],"designed":[112],"measure":[114],"antibodies.":[117],"Vaccination":[118],"with":[119,167,171],"high":[122,152],"antibodies,":[133],"such":[135],"VLP":[138],"6,":[139],"11,":[140],"16":[141],"18":[143],"detected":[146],"Mo":[148],"proportion":[153],"subjects.":[155],"These":[156],"comparable":[159],"greater":[162],"than":[163],"antibody":[164],"associated":[166],"HPV.":[172],"Importantly,":[173],"anti\u2010L1,":[175],"may":[182],"provide":[183],"evidence":[184],"mucosal":[186],"immunity":[187],"that":[188],"could":[189],"protect":[190],"anogenital":[192],"tract":[193]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}